Table 5 Analysis of factors related to thrombocytopenia

Age

0.324

–

  > 75 years

1.507 (0.667–3.402)

–

  ≤ 75 years

Reference

–

BMI

0.285

–

  > 28 kg/m²

0.334 (0.045–2.493)

–

  ≤ 28 kg/m²

Reference

–

History of diabetes mellitus

0.970

–

 Yes

0.984 (0.425–2.276)

–

 No

Reference

–

History of allergy

0.247

–

 Yes

1.798 (0.666–4.853)

–

 No

Reference

–

History of cardiac surgery

0.181

–

 Yes

2.105 (0.708–6.262)

–

 No

Reference

–

History of renal function impairment

0.181

–

 Yes

2.771 (0.622–12.347)

–

 No

Reference

–

History of critical respiratory disease

0.587

–

 Yes

1.765 (0.228–13.689)

–

 No

Reference

–

Clinical presentation-UA

0.032

0.187

 Yes

0.343 (0.129–0.915)

0.492 (0.171–1.412)

 No

Reference

Reference

Clinical presentation-STEMI

0.895

–

 Yes

1.055 (0.477–2.331)

–

 No

Reference

–

Clinical presentation-NSTMI

0.656

–

 Yes

0.759 (0.225–2.558)

–

 No

Reference

–

Clinical presentation-SCAD

 < 0.001

0.002

 Yes

4.450 (1.942–10.198)

4.388 (1.754–10.981)

 No

Reference

Reference

CRUSADE risk stratification

0.122

–

 High risk

1.854 (0.848–4.052)

–

 No high risk

Reference

–

Operative timing

0.767

–

 Elective operation

0.889 (0.408–1.938)

–

 Emergency operation

Reference

–

Types of coronary interventional therapy

0.665

–

 Stent implantation

0.672 (0.111–4.056)

–

 Others

Reference

–

Types of stents

0.410

–

 Drug stent

0.419 (0.053–3.313)

–

 Others

Reference

–

Arterial access

0.163

–

 Radial artery

0.460 (0.155–1.370)

–

 Others

Reference

–

Culprit vessel

0.022

0.010

 Multiple

2.503 (1.143–5.483)

2.974 (1.302–6.792)

 Single

Reference

Reference

Administration of bivalirudin-preoperative or intraoperative

0.036

0.081

 Yes

3.853 (1.095–13.553)

3.220 (0.867–11.953)

 No

Reference

Reference

Administration of bivalirudin-postoperative ≤ 4 h

0.962

–

 Yes

1.027 (0.350–3.016)

–

 No

Reference

–

Administration of bivalirudin-postoperative > 4 h

0.216

–

 Yes

0.282 (0.038–2.098)

–

 No

Reference

–

Combined with GP IIb/IIIa inhibitors

0.281

–

 Yes

1.716 (0.643–4.581)

–

 No

Reference

–

TIMI flow grade (pre–procedure)

0.074

–

 2–3

0.492 (0.226–1.072)

–

 0–1

Reference

–

TIMI flow grade (post-procedure)

0.999

–

 2–3

–

–

 0–1

–

–